Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...
Future Market Insights7 天
Surging Demand for Alpha Olefins in Personal Care and Packaging Sectors Drives Market ...
The alpha olefin market is witnessing substantial growth, with the global market size projected to reach USD 7.6 billion in 2024 and forecasted to grow to USD 13.5 billion by 2034, reflecting a robust ...
C&EN17 天
Effect of Lipidation on the Structure, Oligomerization, and Aggregation of Glucagon-like ...
This work provides a systematic study of the solubility, structure, oligomerization, and long-term stability of five different lipidated analogues of GLP-1, varying in the position of the lipidation ...
C&EN24 天
Comment on “Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways ...
Université de Bourgogne, U1231 INSERM, CTM, Equipe DesCarTes, UFR Sciences de Santé, 7 Bd Jeanne d’Arc, 21078 Dijon Cedex, France ...